Skip to main content
NCBI home page
The EMBO Journal logoLink to The EMBO Journal
. 1998 Aug 3;17(15):4313–4327. doi: 10.1093/emboj/17.15.4313

Structural analysis of the GAP-related domain from neurofibromin and its implications.

K Scheffzek 1, M R Ahmadian 1, L Wiesmüller 1, W Kabsch 1, P Stege 1, F Schmitz 1, A Wittinghofer 1
PMCID: PMC1170765  PMID: 9687500

Abstract

Neurofibromin is the product of the NF1 gene, whose alteration is responsible for the pathogenesis of neurofibromatosis type 1 (NF1), one of the most frequent genetic disorders in man. It acts as a GTPase activating protein (GAP) on Ras; based on homology to p120GAP, a segment spanning 250-400 aa and termed GAP-related domain (NF1GRD; 25-40 kDa) has been shown to be responsible for GAP activity and represents the only functionally defined segment of neurofibromin. Missense mutations found in NF1 patients map to NF1GRD, underscoring its importance for pathogenesis. X-ray crystallographic analysis of a proteolytically treated catalytic fragment of NF1GRD comprising residues 1198-1530 (NF1-333) of human neurofibromin reveals NF1GRD as a helical protein that resembles the corresponding fragment derived from p120GAP (GAP-334). A central domain (NF1c) containing all residues conserved among RasGAPs is coupled to an extra domain (NF1ex), which despite very limited sequence homology is surprisingly similar to the corresponding part of GAP-334. Numerous point mutations found in NF1 patients or derived from genetic screening protocols can be analysed on the basis of the three-dimensional structural model, which also allows identification of the site where structural changes in a differentially spliced isoform are to be expected. Based on the structure of the complex between Ras and GAP-334 described earlier, a model of the NF1GRD-Ras complex is proposed which is used to discuss the strikingly different properties of the Ras-p120GAP and Ras-neurofibromin interactions.

Full Text

The Full Text of this article is available as a PDF (953.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmadian M. R., Hoffmann U., Goody R. S., Wittinghofer A. Individual rate constants for the interaction of Ras proteins with GTPase-activating proteins determined by fluorescence spectroscopy. Biochemistry. 1997 Apr 15;36(15):4535–4541. doi: 10.1021/bi962556y. [DOI] [PubMed] [Google Scholar]
  2. Ahmadian M. R., Stege P., Scheffzek K., Wittinghofer A. Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nat Struct Biol. 1997 Sep;4(9):686–689. doi: 10.1038/nsb0997-686. [DOI] [PubMed] [Google Scholar]
  3. Ahmadian M. R., Wiesmüller L., Lautwein A., Bischoff F. R., Wittinghofer A. Structural differences in the minimal catalytic domains of the GTPase-activating proteins p120GAP and neurofibromin. J Biol Chem. 1996 Jul 5;271(27):16409–16415. doi: 10.1074/jbc.271.27.16409. [DOI] [PubMed] [Google Scholar]
  4. Andersen L. B., Ballester R., Marchuk D. A., Chang E., Gutmann D. H., Saulino A. M., Camonis J., Wigler M., Collins F. S. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol. 1993 Jan;13(1):487–495. doi: 10.1128/mcb.13.1.487-495.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bader J. L. Neurofibromatosis and cancer. Ann N Y Acad Sci. 1986;486:57–65. doi: 10.1111/j.1749-6632.1986.tb48062.x. [DOI] [PubMed] [Google Scholar]
  6. Ballester R., Marchuk D., Boguski M., Saulino A., Letcher R., Wigler M., Collins F. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell. 1990 Nov 16;63(4):851–859. doi: 10.1016/0092-8674(90)90151-4. [DOI] [PubMed] [Google Scholar]
  7. Basu T. N., Gutmann D. H., Fletcher J. A., Glover T. W., Collins F. S., Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature. 1992 Apr 23;356(6371):713–715. doi: 10.1038/356713a0. [DOI] [PubMed] [Google Scholar]
  8. Bollag G., McCormick F., Clark R. Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity. EMBO J. 1993 May;12(5):1923–1927. doi: 10.1002/j.1460-2075.1993.tb05841.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bollag G., McCormick F. Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature. 1991 Jun 13;351(6327):576–579. doi: 10.1038/351576a0. [DOI] [PubMed] [Google Scholar]
  10. Brannan C. I., Perkins A. S., Vogel K. S., Ratner N., Nordlund M. L., Reid S. W., Buchberg A. M., Jenkins N. A., Parada L. F., Copeland N. G. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 1994 May 1;8(9):1019–1029. doi: 10.1101/gad.8.9.1019. [DOI] [PubMed] [Google Scholar]
  11. Brownbridge G. G., Lowe P. N., Moore K. J., Skinner R. H., Webb M. R. Interaction of GTPase activating proteins (GAPs) with p21ras measured by a novel fluorescence anisotropy method. Essential role of Arg-903 of GAP in activation of GTP hydrolysis on p21ras. J Biol Chem. 1993 May 25;268(15):10914–10919. [PubMed] [Google Scholar]
  12. Cawthon R. M., Weiss R., Xu G. F., Viskochil D., Culver M., Stevens J., Robertson M., Dunn D., Gesteland R., O'Connell P. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990 Jul 13;62(1):193–201. doi: 10.1016/0092-8674(90)90253-b. [DOI] [PubMed] [Google Scholar]
  13. Chabre M. Aluminofluoride and beryllofluoride complexes: a new phosphate analogs in enzymology. Trends Biochem Sci. 1990 Jan;15(1):6–10. doi: 10.1016/0968-0004(90)90117-t. [DOI] [PubMed] [Google Scholar]
  14. DeClue J. E., Cohen B. D., Lowy D. R. Identification and characterization of the neurofibromatosis type 1 protein product. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9914–9918. doi: 10.1073/pnas.88.22.9914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. DeClue J. E., Papageorge A. G., Fletcher J. A., Diehl S. R., Ratner N., Vass W. C., Lowy D. R. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell. 1992 Apr 17;69(2):265–273. doi: 10.1016/0092-8674(92)90407-4. [DOI] [PubMed] [Google Scholar]
  16. Eccleston J. F., Moore K. J., Morgan L., Skinner R. H., Lowe P. N. Kinetics of interaction between normal and proline 12 Ras and the GTPase-activating proteins, p120-GAP and neurofibromin. The significance of the intrinsic GTPase rate in determining the transforming ability of ras. J Biol Chem. 1993 Dec 25;268(36):27012–27019. [PubMed] [Google Scholar]
  17. Fridman M., Tikoo A., Varga M., Murphy A., Nur-E-Kamal M. S., Maruta H. The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype. J Biol Chem. 1994 Dec 2;269(48):30105–30108. [PubMed] [Google Scholar]
  18. Gaul U., Mardon G., Rubin G. M. A putative Ras GTPase activating protein acts as a negative regulator of signaling by the Sevenless receptor tyrosine kinase. Cell. 1992 Mar 20;68(6):1007–1019. doi: 10.1016/0092-8674(92)90073-l. [DOI] [PubMed] [Google Scholar]
  19. Geyer M., Schweins T., Herrmann C., Prisner T., Wittinghofer A., Kalbitzer H. R. Conformational transitions in p21ras and in its complexes with the effector protein Raf-RBD and the GTPase activating protein GAP. Biochemistry. 1996 Aug 13;35(32):10308–10320. doi: 10.1021/bi952858k. [DOI] [PubMed] [Google Scholar]
  20. Gideon P., John J., Frech M., Lautwein A., Clark R., Scheffler J. E., Wittinghofer A. Mutational and kinetic analyses of the GTPase-activating protein (GAP)-p21 interaction: the C-terminal domain of GAP is not sufficient for full activity. Mol Cell Biol. 1992 May;12(5):2050–2056. doi: 10.1128/mcb.12.5.2050-2056.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Golubić M., Tanaka K., Dobrowolski S., Wood D., Tsai M. H., Marshall M., Tamanoi F., Stacey D. W. The GTPase stimulatory activities of the neurofibromatosis type 1 and the yeast IRA2 proteins are inhibited by arachidonic acid. EMBO J. 1991 Oct;10(10):2897–2903. doi: 10.1002/j.1460-2075.1991.tb07839.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gregory P. E., Gutmann D. H., Mitchell A., Park S., Boguski M., Jacks T., Wood D. L., Jove R., Collins F. S. Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet. 1993 May;19(3):265–274. doi: 10.1007/BF01233074. [DOI] [PubMed] [Google Scholar]
  23. Griesser J., Kaufmann D., Eisenbarth I., Bäuerle C., Krone W. Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1). Biol Chem Hoppe Seyler. 1995 Feb;376(2):91–101. doi: 10.1515/bchm3.1995.376.2.91. [DOI] [PubMed] [Google Scholar]
  24. Guha A., Lau N., Huvar I., Gutmann D., Provias J., Pawson T., Boss G. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene. 1996 Feb 1;12(3):507–513. [PubMed] [Google Scholar]
  25. Gutmann D. H., Boguski M., Marchuk D., Wigler M., Collins F. S., Ballester R. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis. Oncogene. 1993 Mar;8(3):761–769. [PubMed] [Google Scholar]
  26. Gutmann D. H., Collins F. S. The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron. 1993 Mar;10(3):335–343. doi: 10.1016/0896-6273(93)90324-k. [DOI] [PubMed] [Google Scholar]
  27. Gutmann D. H., Geist R. T., Rose K., Wright D. E. Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues. Dev Dyn. 1995 Mar;202(3):302–311. doi: 10.1002/aja.1002020309. [DOI] [PubMed] [Google Scholar]
  28. Henkemeyer M., Rossi D. J., Holmyard D. P., Puri M. C., Mbamalu G., Harpal K., Shih T. S., Jacks T., Pawson T. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature. 1995 Oct 26;377(6551):695–701. doi: 10.1038/377695a0. [DOI] [PubMed] [Google Scholar]
  29. Jacks T., Shih T. S., Schmitt E. M., Bronson R. T., Bernards A., Weinberg R. A. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet. 1994 Jul;7(3):353–361. doi: 10.1038/ng0794-353. [DOI] [PubMed] [Google Scholar]
  30. Johnson M. R., DeClue J. E., Felzmann S., Vass W. C., Xu G., White R., Lowy D. R. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol. 1994 Jan;14(1):641–645. doi: 10.1128/mcb.14.1.641-645.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Jones T. A., Zou J. Y., Cowan S. W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991 Mar 1;47(Pt 2):110–119. doi: 10.1107/s0108767390010224. [DOI] [PubMed] [Google Scholar]
  32. Kabsch W., Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983 Dec;22(12):2577–2637. doi: 10.1002/bip.360221211. [DOI] [PubMed] [Google Scholar]
  33. Klose A., Ahmadian M. R., Schuelke M., Scheffzek K., Hoffmeyer S., Gewies A., Schmitz F., Kaufmann D., Peters H., Wittinghofer A. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. Hum Mol Genet. 1998 Aug;7(8):1261–1268. doi: 10.1093/hmg/7.8.1261. [DOI] [PubMed] [Google Scholar]
  34. Li Y., Bollag G., Clark R., Stevens J., Conroy L., Fults D., Ward K., Friedman E., Samowitz W., Robertson M. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell. 1992 Apr 17;69(2):275–281. doi: 10.1016/0092-8674(92)90408-5. [DOI] [PubMed] [Google Scholar]
  35. Lowy D. R., Willumsen B. M. Function and regulation of ras. Annu Rev Biochem. 1993;62:851–891. doi: 10.1146/annurev.bi.62.070193.004223. [DOI] [PubMed] [Google Scholar]
  36. Löwe J., Amos L. A. Crystal structure of the bacterial cell-division protein FtsZ. Nature. 1998 Jan 8;391(6663):203–206. doi: 10.1038/34472. [DOI] [PubMed] [Google Scholar]
  37. Marchuk D. A., Saulino A. M., Tavakkol R., Swaroop M., Wallace M. R., Andersen L. B., Mitchell A. L., Gutmann D. H., Boguski M., Collins F. S. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics. 1991 Dec;11(4):931–940. doi: 10.1016/0888-7543(91)90017-9. [DOI] [PubMed] [Google Scholar]
  38. Marshall M. S., Hill W. S., Ng A. S., Vogel U. S., Schaber M. D., Scolnick E. M., Dixon R. A., Sigal I. S., Gibbs J. B. A C-terminal domain of GAP is sufficient to stimulate ras p21 GTPase activity. EMBO J. 1989 Apr;8(4):1105–1110. doi: 10.1002/j.1460-2075.1989.tb03480.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Martin G. A., Viskochil D., Bollag G., McCabe P. C., Crosier W. J., Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R. M. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell. 1990 Nov 16;63(4):843–849. doi: 10.1016/0092-8674(90)90150-d. [DOI] [PubMed] [Google Scholar]
  40. Merritt E. A., Bacon D. J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 1997;277:505–524. doi: 10.1016/s0076-6879(97)77028-9. [DOI] [PubMed] [Google Scholar]
  41. Milburn M. V., Tong L., deVos A. M., Brünger A., Yamaizumi Z., Nishimura S., Kim S. H. Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science. 1990 Feb 23;247(4945):939–945. doi: 10.1126/science.2406906. [DOI] [PubMed] [Google Scholar]
  42. Mittal R., Ahmadian M. R., Goody R. S., Wittinghofer A. Formation of a transition-state analog of the Ras GTPase reaction by Ras-GDP, tetrafluoroaluminate, and GTPase-activating proteins. Science. 1996 Jul 5;273(5271):115–117. doi: 10.1126/science.273.5271.115. [DOI] [PubMed] [Google Scholar]
  43. Morcos P., Thapar N., Tusneem N., Stacey D., Tamanoi F. Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles. Mol Cell Biol. 1996 May;16(5):2496–2503. doi: 10.1128/mcb.16.5.2496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Mori S., Satoh T., Koide H., Nakafuku M., Villafranca E., Kaziro Y. Inhibition of Ras/Raf interaction by anti-oncogenic mutants of neurofibromin, the neurofibromatosis type 1 (NF1) gene product, in cell-free systems. J Biol Chem. 1995 Dec 1;270(48):28834–28838. doi: 10.1074/jbc.270.48.28834. [DOI] [PubMed] [Google Scholar]
  45. Nakafuku M., Nagamine M., Ohtoshi A., Tanaka K., Toh-e A., Kaziro Y. Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6706–6710. doi: 10.1073/pnas.90.14.6706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Nishi T., Lee P. S., Oka K., Levin V. A., Tanase S., Morino Y., Saya H. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Oncogene. 1991 Sep;6(9):1555–1559. [PubMed] [Google Scholar]
  47. Nixon A. E., Brune M., Lowe P. N., Webb M. R. Kinetics of inorganic phosphate release during the interaction of p21ras with the GTPase-activating proteins, p120-GAP and neurofibromin. Biochemistry. 1995 Nov 28;34(47):15592–15598. doi: 10.1021/bi00047a026. [DOI] [PubMed] [Google Scholar]
  48. Nogales E., Wolf S. G., Downing K. H. Structure of the alpha beta tubulin dimer by electron crystallography. Nature. 1998 Jan 8;391(6663):199–203. doi: 10.1038/34465. [DOI] [PubMed] [Google Scholar]
  49. Nur-E-Kamal M. S., Varga M., Maruta H. The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype. J Biol Chem. 1993 Oct 25;268(30):22331–22337. [PubMed] [Google Scholar]
  50. Pai E. F., Krengel U., Petsko G. A., Goody R. S., Kabsch W., Wittinghofer A. Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. EMBO J. 1990 Aug;9(8):2351–2359. doi: 10.1002/j.1460-2075.1990.tb07409.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ponder B. A. Inherited predisposition to cancer. Trends Genet. 1990 Jul;6(7):213–218. doi: 10.1016/0168-9525(90)90181-5. [DOI] [PubMed] [Google Scholar]
  52. Poullet P., Lin B., Esson K., Tamanoi F. Functional significance of lysine 1423 of neurofibromin and characterization of a second site suppressor which rescues mutations at this residue and suppresses RAS2Val-19-activated phenotypes. Mol Cell Biol. 1994 Jan;14(1):815–821. doi: 10.1128/mcb.14.1.815-821.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Purandare S. M., Lanyon W. G., Connor J. M. Characterisation of inherited and sporadic mutations in neurofibromatosis type-1. Hum Mol Genet. 1994 Jul;3(7):1109–1115. doi: 10.1093/hmg/3.7.1109. [DOI] [PubMed] [Google Scholar]
  54. Rey I., Taylor-Harris P., van Erp H., Hall A. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation. Oncogene. 1994 Mar;9(3):685–692. [PubMed] [Google Scholar]
  55. Riccardi V. M. Neurofibromatosis: past, present, and future. N Engl J Med. 1991 May 2;324(18):1283–1285. doi: 10.1056/NEJM199105023241812. [DOI] [PubMed] [Google Scholar]
  56. Riccardi V. M. Von Recklinghausen neurofibromatosis. N Engl J Med. 1981 Dec 31;305(27):1617–1627. doi: 10.1056/NEJM198112313052704. [DOI] [PubMed] [Google Scholar]
  57. Scheffzek K., Ahmadian M. R., Kabsch W., Wiesmüller L., Lautwein A., Schmitz F., Wittinghofer A. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science. 1997 Jul 18;277(5324):333–338. doi: 10.1126/science.277.5324.333. [DOI] [PubMed] [Google Scholar]
  58. Scheffzek K., Lautwein A., Kabsch W., Ahmadian M. R., Wittinghofer A. Crystal structure of the GTPase-activating domain of human p120GAP and implications for the interaction with Ras. Nature. 1996 Dec 12;384(6609):591–596. doi: 10.1038/384591a0. [DOI] [PubMed] [Google Scholar]
  59. Serra E., Puig S., Otero D., Gaona A., Kruyer H., Ars E., Estivill X., Lázaro C. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet. 1997 Sep;61(3):512–519. doi: 10.1086/515504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Serth J., Lautwein A., Frech M., Wittinghofer A., Pingoud A. The inhibition of the GTPase activating protein-Ha-ras interaction by acidic lipids is due to physical association of the C-terminal domain of the GTPase activating protein with micellar structures. EMBO J. 1991 Jun;10(6):1325–1330. doi: 10.1002/j.1460-2075.1991.tb07651.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Shen M. H., Harper P. S., Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet. 1996 Jan;33(1):2–17. doi: 10.1136/jmg.33.1.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Skinner R. H., Picardo M., Gane N. M., Cook N. D., Morgan L., Rowedder J., Lowe P. N. Direct measurement of the binding of RAS to neurofibromin using a scintillation proximity assay. Anal Biochem. 1994 Dec;223(2):259–265. doi: 10.1006/abio.1994.1582. [DOI] [PubMed] [Google Scholar]
  63. Stanbridge E. J. Human tumor suppressor genes. Annu Rev Genet. 1990;24:615–657. doi: 10.1146/annurev.ge.24.120190.003151. [DOI] [PubMed] [Google Scholar]
  64. Suzuki Y., Suzuki H., Kayama T., Yoshimoto T., Shibahara S. Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain. Biochem Biophys Res Commun. 1991 Dec 31;181(3):955–961. doi: 10.1016/0006-291x(91)92029-j. [DOI] [PubMed] [Google Scholar]
  65. Tanaka K., Lin B. K., Wood D. R., Tamanoi F. IRA2, an upstream negative regulator of RAS in yeast, is a RAS GTPase-activating protein. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):468–472. doi: 10.1073/pnas.88.2.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Tanaka K., Nakafuku M., Satoh T., Marshall M. S., Gibbs J. B., Matsumoto K., Kaziro Y., Toh-e A. S. cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein. Cell. 1990 Mar 9;60(5):803–807. doi: 10.1016/0092-8674(90)90094-u. [DOI] [PubMed] [Google Scholar]
  67. Tanaka K., Nakafuku M., Tamanoi F., Kaziro Y., Matsumoto K., Toh-e A. IRA2, a second gene of Saccharomyces cerevisiae that encodes a protein with a domain homologous to mammalian ras GTPase-activating protein. Mol Cell Biol. 1990 Aug;10(8):4303–4313. doi: 10.1128/mcb.10.8.4303-4313.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. The I., Hannigan G. E., Cowley G. S., Reginald S., Zhong Y., Gusella J. F., Hariharan I. K., Bernards A. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science. 1997 May 2;276(5313):791–794. doi: 10.1126/science.276.5313.791. [DOI] [PubMed] [Google Scholar]
  69. Trahey M., McCormick F. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science. 1987 Oct 23;238(4826):542–545. doi: 10.1126/science.2821624. [DOI] [PubMed] [Google Scholar]
  70. Tsai M. H., Roudebush M., Dobrowolski S., Yu C. L., Gibbs J. B., Stacey D. W. Ras GTPase-activating protein physically associates with mitogenically active phospholipids. Mol Cell Biol. 1991 May;11(5):2785–2793. doi: 10.1128/mcb.11.5.2785-2793.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Upadhyaya M., Osborn M. J., Maynard J., Kim M. R., Tamanoi F., Cooper D. N. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet. 1997 Jan;99(1):88–92. doi: 10.1007/s004390050317. [DOI] [PubMed] [Google Scholar]
  72. Viskochil D., Buchberg A. M., Xu G., Cawthon R. M., Stevens J., Wolff R. K., Culver M., Carey J. C., Copeland N. G., Jenkins N. A. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990 Jul 13;62(1):187–192. doi: 10.1016/0092-8674(90)90252-a. [DOI] [PubMed] [Google Scholar]
  73. Wallace M. R., Marchuk D. A., Andersen L. B., Letcher R., Odeh H. M., Saulino A. M., Fountain J. W., Brereton A., Nicholson J., Mitchell A. L. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990 Jul 13;249(4965):181–186. doi: 10.1126/science.2134734. [DOI] [PubMed] [Google Scholar]
  74. Wiesmüller L., Wittinghofer A. Expression of the GTPase activating domain of the neurofibromatosis type 1 (NF1) gene in Escherichia coli and role of the conserved lysine residue. J Biol Chem. 1992 May 25;267(15):10207–10210. [PubMed] [Google Scholar]
  75. Wittinghofer A. Signaling mechanistics: aluminum fluoride for molecule of the year. Curr Biol. 1997 Nov 1;7(11):R682–R685. doi: 10.1016/s0960-9822(06)00355-1. [DOI] [PubMed] [Google Scholar]
  76. Wolber V., Maeda K., Schumann R., Brandmeier B., Wiesmüller L., Wittinghofer A. A universal expression-purification system based on the coiled-coil interaction of myosin heavy chain. Biotechnology (N Y) 1992 Aug;10(8):900–904. doi: 10.1038/nbt0892-900. [DOI] [PubMed] [Google Scholar]
  77. Wood D. R., Poullet P., Wilson B. A., Khalil M., Tanaka K., Cannon J. F., Tamanoi F. Biochemical characterization of yeast RAS2 mutants reveals a new region of ras protein involved in the interaction with GTPase-activating proteins. J Biol Chem. 1994 Feb 18;269(7):5322–5327. [PubMed] [Google Scholar]
  78. Xu G. F., Lin B., Tanaka K., Dunn D., Wood D., Gesteland R., White R., Weiss R., Tamanoi F. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell. 1990 Nov 16;63(4):835–841. doi: 10.1016/0092-8674(90)90149-9. [DOI] [PubMed] [Google Scholar]
  79. Xu G. F., O'Connell P., Viskochil D., Cawthon R., Robertson M., Culver M., Dunn D., Stevens J., Gesteland R., White R. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990 Aug 10;62(3):599–608. doi: 10.1016/0092-8674(90)90024-9. [DOI] [PubMed] [Google Scholar]
  80. Xu H., Gutmann D. H. Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules. Brain Res. 1997 Jun 6;759(1):149–152. doi: 10.1016/s0006-8993(97)00328-4. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES